MEMPHASYS LIMITED. - Announcements

0.00%

0.4¢

Market Cap $7.934M

Technology Scientific & Technical Instruments

Memphasys Ltd is a listed Australian MedTech company (ASX: MEM) focussed on reproductive... Memphasys Ltd is a listed Australian MedTech company (ASX: MEM) focussed on reproductive biotechnology. Driven by market needs, Memphasys is developing a portfolio of device, diagnostic and media products that address human and animal reproduction issues.More

Corporate Spotlight

Memphasys Ltd is a listed Australian MedTech company (ASX: MEM) focussed on reproductive biotechnology. Driven by market needs, Memphasys is developing a portfolio of device, diagnostic and media products that address human and animal reproduction issues.
View the full Corporate Spotlight

LATEST INTERVIEW

Announcements

Filter Results

All Price Sensitive Only

Filters [Clear]

Price Sensitive: Yes

MEM	Preliminary Final Report	PRICE SENSITIVE	27/08/20	1.03MB	Share
MEM	Half Yearly Report and Accounts	PRICE SENSITIVE	25/02/20	8.67MB	Share
MEM	Response to ASX Price Query	PRICE SENSITIVE	08/10/19	512.44KB	Share
MEM	Pause in Trading	PRICE SENSITIVE	08/10/19	116.25KB	Share
MEM	Preliminary Final Report	PRICE SENSITIVE	28/08/19	168.96KB	Share
MEM	Response to ASX Price Query	PRICE SENSITIVE	17/07/19	469.79KB	Share
MEM	MEM appoints FELIX manufacturer and raises new capital	PRICE SENSITIVE	09/07/19	241.51KB	Share
MEM	Trading Halt	PRICE SENSITIVE	05/07/19	497.61KB	Share
MEM	Cleansing Prospectus	PRICE SENSITIVE	05/06/19	241.19KB	Share
MEM	Rights Issue Prospectus shortfall	PRICE SENSITIVE	26/03/19	153.37KB	Share
MEM	Rights Issue Prospectus	PRICE SENSITIVE	01/03/19	459.51KB	Share
MEM	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/19	409.79KB	Share
MEM	Entitlement issue and dual listing	PRICE SENSITIVE	27/02/19	69.36KB	Share
MEM	Trading Halt	PRICE SENSITIVE	25/02/19	516.23KB	Share
MEM	Response to ASX aware query	PRICE SENSITIVE	23/10/18	481.82KB	Share
MEM	Response to ASX price query	PRICE SENSITIVE	18/10/18	397.49KB	Share
MEM	Pause in trading	PRICE SENSITIVE	18/10/18	116.23KB	Share
MEM	Collaborative Agreement with Monash IVF Group	PRICE SENSITIVE	18/09/18	501.15KB	Share
MEM	Preliminary Final Report	PRICE SENSITIVE	24/08/18	167.31KB	Share
MEM	Proposed share consolidaiton	PRICE SENSITIVE	03/07/18	156.25KB	Share
MEM	Memphasys raises $1m via a strategic investment	PRICE SENSITIVE	25/05/18	243.14KB	Share
MEM	Felix device development update	PRICE SENSITIVE	03/05/18	896.04KB	Share
MEM	Appendix 4D - December 2017 Half year Financial Accounts	PRICE SENSITIVE	23/02/18	1005.62KB	Share
MEM	Legal action with Platinum Road / Bridge Road Capital	PRICE SENSITIVE	13/02/18	676.01KB	Share
MEM	$400,000 Special Grant received from the NSW Medical Devices	PRICE SENSITIVE	22/12/17	248.1KB	Share
MEM	MEM Non-Renounceable Rights Issue Offer	PRICE SENSITIVE	28/11/17	282.39KB	Share
MEM	Rights Offer Cleaning Notice	PRICE SENSITIVE	28/11/17	68.48KB	Share
MEM	$400,000 special grant offer from NSW Medical Devices Fund	PRICE SENSITIVE	24/11/17	168.3KB	Share
MEM	$3.75M Capital Raising to Accelerate Dev of Felix Device	PRICE SENSITIVE	21/11/17	733.08KB	Share
MEM	Advanced development of Felix device supported by R&D rebate	PRICE SENSITIVE	10/10/17	506.13KB	Share
MEM	Adjusting amendment to Appendix 4E	PRICE SENSITIVE	13/09/17	437.04KB	Share
MEM	Appendix 4E Preliminary Final Report	PRICE SENSITIVE	31/08/17	158.87KB	Share
MEM	Correction to Outcome of Litigation	PRICE SENSITIVE	28/07/17	402.59KB	Share
MEM	Outcome of Litigation	PRICE SENSITIVE	27/07/17	369.23KB	Share
MEM	Trading Halt	PRICE SENSITIVE	25/07/17	468.17KB	Share
MEM	Felix Project development update	PRICE SENSITIVE	13/07/17	438.21KB	Share
MEM	Extension of Director line of credit	PRICE SENSITIVE	03/07/17	115.19KB	Share
MEM	SpermSep device development update	PRICE SENSITIVE	29/06/17	122.48KB	Share
MEM	Update on SpermSep Device Development	PRICE SENSITIVE	18/05/17	141.14KB	Share
MEM	Completes sale of Gels business and Crescendas Loan clarific	PRICE SENSITIVE	06/04/17	92.73KB	Share
MEM	Commence next phase of SpermSep Development and new funding	PRICE SENSITIVE	04/04/17	77.83KB	Share
MEM	Loan from Crescendas Projects and PrIME legal dispute update	PRICE SENSITIVE	02/03/17	69.46KB	Share
MEM	Appendix 4D and Half Year Financial Accounts	PRICE SENSITIVE	28/02/17	578.39KB	Share
MEM	Funding Update - loan and line of credit	PRICE SENSITIVE	23/02/17	506.54KB	Share
MEM	Update on Dispute Resolution Process	PRICE SENSITIVE	17/02/17	66.54KB	Share
MEM	Statutory Demand To Be Set Aside	PRICE SENSITIVE	15/02/17	461.43KB	Share
MEM	Memphasys' Capital Raising Review	PRICE SENSITIVE	16/12/16	301.33KB	Share
MEM	Capital Raising	PRICE SENSITIVE	12/12/16	460.5KB	Share
MEM	STATEMENT OF CLAIM FROM TRANSOCEAN SECURITIES	PRICE SENSITIVE	21/11/16	399.56KB	Share
MEM	UPDATE ON LITIGATION AGAINST PRIME	PRICE SENSITIVE	11/11/16	535.03KB	Share
MEM	Capital Raising and New Corporate Advisor-MEM.AX	PRICE SENSITIVE	20/09/16	271.28KB	Share
MEM	Trading Halt-MEM.AX	PRICE SENSITIVE	16/09/16	518.51KB	Share
MEM	Letter of Demand from PrIME and Manukan re A-Bio Debt Repaym-MEM.AX	PRICE SENSITIVE	12/09/16	255.54KB	Share
MEM	Appendix 4E & FY2016 Preliminary Final Report-MEM.AX	PRICE SENSITIVE	31/08/16	218.52KB	Share
MEM	Extended Date for A-Bio Debt Repayment-NSP.AX	PRICE SENSITIVE	02/06/16	313.46KB	Share
MEM	PrIME Capital Raising-NSP.AX	PRICE SENSITIVE	16/05/16	403.46KB	Share
MEM	Reinstatement to Official Quotation-NSP.AX	PRICE SENSITIVE	02/05/16	247.36KB	Share
MEM	Continuing Negotiations on sale of B Class shares in PrIME-NSP.AX	PRICE SENSITIVE	02/05/16	485.21KB	Share
MEM	Suspension from Official Quotation-NSP.AX	PRICE SENSITIVE	26/04/16	624.72KB	Share
MEM	Trading Halt-NSP.AX	PRICE SENSITIVE	21/04/16	659.86KB	Share
MEM	Non-Renounceable Entitlement Issue Closure	PRICE SENSITIVE	15/03/16	305.06KB	Share
MEM	Replacement Prospectus	PRICE SENSITIVE	26/02/16	1.2MB	Share
MEM	Appendix 4D and Half Year Report December 2015	PRICE SENSITIVE	26/02/16	1.04MB	Share
MEM	University of Newcastle Agreement	PRICE SENSITIVE	22/02/16	406.04KB	Share
MEM	Non-renounceable Entitlement Offer	PRICE SENSITIVE	16/02/16	389.14KB	Share
MEM	Non-Renounceable Issue	PRICE SENSITIVE	16/02/16	1.79MB	Share
MEM	Entitlement Offer and Appendix 3B	PRICE SENSITIVE	15/02/16	1015.08KB	Share
MEM	Private placement	PRICE SENSITIVE	11/01/16	388.62KB	Share
MEM	Trading Halt	PRICE SENSITIVE	07/01/16	460.21KB	Share
MEM	Loan from A Goodall	PRICE SENSITIVE	18/11/15	309.48KB	Share
MEM	Settlement of dispute with former Managing Director	PRICE SENSITIVE	13/11/15	116.28KB	Share
MEM	Half Year Accounts	PRICE SENSITIVE	01/09/15	268.77KB	Share
MEM	START OF IN-VITRO CLINICAL TRIAL AT MONASH IVF	PRICE SENSITIVE	10/08/15	503.88KB	Share
MEM	Security Purchase Plan	PRICE SENSITIVE	10/08/15	1.02MB	Share
MEM	Proposed Sale of Interest in PrIME Biologics Pte Limited	PRICE SENSITIVE	23/07/15	282.78KB	Share
MEM	ASIC Investigation of NuSep Concluded	PRICE SENSITIVE	09/07/15	350.15KB	Share
MEM	Receipt of Short Term Loan and Market Update	PRICE SENSITIVE	29/06/15	316.96KB	Share
MEM	NuSep Receives Short Term Loan from Singapore Company	PRICE SENSITIVE	10/04/15	304.92KB	Share
MEM	Half Yearly Report and Accounts	PRICE SENSITIVE	02/03/15	1.1MB	Share
MEM	Enforceable Undertaking	PRICE SENSITIVE	18/12/14	1.46MB	Share
MEM	R&D Tax Refund	PRICE SENSITIVE	18/12/14	241.56KB	Share
MEM	Supply of Membranes to Prime Biologics Pte Ltd	PRICE SENSITIVE	04/11/14	305.09KB	Share
MEM	NuSep signs Heads of Agreement with Minitub GmbH	PRICE SENSITIVE	04/11/14	469.25KB	Share
MEM	Market Update	PRICE SENSITIVE	08/10/14	456.01KB	Share
MEM	Appendix 4E	PRICE SENSITIVE	01/09/14	660.21KB	Share
MEM	Payment Renegotiation for Singapore Processing Facility	PRICE SENSITIVE	05/06/14	544.51KB	Share
MEM	Off Market Share Transaction	PRICE SENSITIVE	12/05/14	296.75KB	Share
MEM	Investment Transaction For PrIME Biologics Private Limited	PRICE SENSITIVE	09/05/14	324.16KB	Share
MEM	Trading Halt	PRICE SENSITIVE	07/05/14	317.01KB	Share
MEM	Loan Facilities	PRICE SENSITIVE	03/03/14	150.05KB	Share
MEM	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/14	366.22KB	Share
MEM	Placement	PRICE SENSITIVE	19/02/14	146.77KB	Share
MEM	Change in Chief Executive Officer	PRICE SENSITIVE	11/02/14	148.01KB	Share
MEM	Proposed Issue of Share Options	PRICE SENSITIVE	24/01/14	56.5KB	Share
MEM	NuSep Working Capital Advance	PRICE SENSITIVE	20/01/14	56.61KB	Share
MEM	PrIME receives Xeraya Board conditional approval for Funding	PRICE SENSITIVE	24/12/13	56.25KB	Share
MEM	PrIME signs Non Binding Funding Term Sheet	PRICE SENSITIVE	29/10/13	72.25KB	Share
MEM	NuSep Receives $1.6m R&D Tax Refund	PRICE SENSITIVE	08/10/13	56.12KB	Share
MEM	NuSep announces 30 June 2013 Full Year Results	PRICE SENSITIVE	30/08/13	121.92KB	Share
MEM	NuSep lodges $1.6m R&D Tax Refund	PRICE SENSITIVE	23/08/13	55.01KB	Share

MEM Preliminary Final Report
27/08/20	PRICE SENSITIVE	1.03MB	Share
MEM Half Yearly Report and Accounts
25/02/20	PRICE SENSITIVE	8.67MB	Share
MEM Response to ASX Price Query
08/10/19	PRICE SENSITIVE	512.44KB	Share
MEM Pause in Trading
08/10/19	PRICE SENSITIVE	116.25KB	Share
MEM Preliminary Final Report
28/08/19	PRICE SENSITIVE	168.96KB	Share
MEM Response to ASX Price Query
17/07/19	PRICE SENSITIVE	469.79KB	Share
MEM MEM appoints FELIX manufacturer and raises new capital
09/07/19	PRICE SENSITIVE	241.51KB	Share
MEM Trading Halt
05/07/19	PRICE SENSITIVE	497.61KB	Share
MEM Cleansing Prospectus
05/06/19	PRICE SENSITIVE	241.19KB	Share
MEM Rights Issue Prospectus shortfall
26/03/19	PRICE SENSITIVE	153.37KB	Share
MEM Rights Issue Prospectus
01/03/19	PRICE SENSITIVE	459.51KB	Share
MEM Half Yearly Report and Accounts
28/02/19	PRICE SENSITIVE	409.79KB	Share
MEM Entitlement issue and dual listing
27/02/19	PRICE SENSITIVE	69.36KB	Share
MEM Trading Halt
25/02/19	PRICE SENSITIVE	516.23KB	Share
MEM Response to ASX aware query
23/10/18	PRICE SENSITIVE	481.82KB	Share
MEM Response to ASX price query
18/10/18	PRICE SENSITIVE	397.49KB	Share
MEM Pause in trading
18/10/18	PRICE SENSITIVE	116.23KB	Share
MEM Collaborative Agreement with Monash IVF Group
18/09/18	PRICE SENSITIVE	501.15KB	Share
MEM Preliminary Final Report
24/08/18	PRICE SENSITIVE	167.31KB	Share
MEM Proposed share consolidaiton
03/07/18	PRICE SENSITIVE	156.25KB	Share
MEM Memphasys raises $1m via a strategic investment
25/05/18	PRICE SENSITIVE	243.14KB	Share
MEM Felix device development update
03/05/18	PRICE SENSITIVE	896.04KB	Share
MEM Appendix 4D - December 2017 Half year Financial Accounts
23/02/18	PRICE SENSITIVE	1005.62KB	Share
MEM Legal action with Platinum Road / Bridge Road Capital
13/02/18	PRICE SENSITIVE	676.01KB	Share
MEM $400,000 Special Grant received from the NSW Medical Devices
22/12/17	PRICE SENSITIVE	248.1KB	Share
MEM MEM Non-Renounceable Rights Issue Offer
28/11/17	PRICE SENSITIVE	282.39KB	Share
MEM Rights Offer Cleaning Notice
28/11/17	PRICE SENSITIVE	68.48KB	Share
MEM $400,000 special grant offer from NSW Medical Devices Fund
24/11/17	PRICE SENSITIVE	168.3KB	Share
MEM $3.75M Capital Raising to Accelerate Dev of Felix Device
21/11/17	PRICE SENSITIVE	733.08KB	Share
MEM Advanced development of Felix device supported by R&D rebate
10/10/17	PRICE SENSITIVE	506.13KB	Share
MEM Adjusting amendment to Appendix 4E
13/09/17	PRICE SENSITIVE	437.04KB	Share
MEM Appendix 4E Preliminary Final Report
31/08/17	PRICE SENSITIVE	158.87KB	Share
MEM Correction to Outcome of Litigation
28/07/17	PRICE SENSITIVE	402.59KB	Share
MEM Outcome of Litigation
27/07/17	PRICE SENSITIVE	369.23KB	Share
MEM Trading Halt
25/07/17	PRICE SENSITIVE	468.17KB	Share
MEM Felix Project development update
13/07/17	PRICE SENSITIVE	438.21KB	Share
MEM Extension of Director line of credit
03/07/17	PRICE SENSITIVE	115.19KB	Share
MEM SpermSep device development update
29/06/17	PRICE SENSITIVE	122.48KB	Share
MEM Update on SpermSep Device Development
18/05/17	PRICE SENSITIVE	141.14KB	Share
MEM Completes sale of Gels business and Crescendas Loan clarific
06/04/17	PRICE SENSITIVE	92.73KB	Share
MEM Commence next phase of SpermSep Development and new funding
04/04/17	PRICE SENSITIVE	77.83KB	Share
MEM Loan from Crescendas Projects and PrIME legal dispute update
02/03/17	PRICE SENSITIVE	69.46KB	Share
MEM Appendix 4D and Half Year Financial Accounts
28/02/17	PRICE SENSITIVE	578.39KB	Share
MEM Funding Update - loan and line of credit
23/02/17	PRICE SENSITIVE	506.54KB	Share
MEM Update on Dispute Resolution Process
17/02/17	PRICE SENSITIVE	66.54KB	Share
MEM Statutory Demand To Be Set Aside
15/02/17	PRICE SENSITIVE	461.43KB	Share
MEM Memphasys' Capital Raising Review
16/12/16	PRICE SENSITIVE	301.33KB	Share
MEM Capital Raising
12/12/16	PRICE SENSITIVE	460.5KB	Share
MEM STATEMENT OF CLAIM FROM TRANSOCEAN SECURITIES
21/11/16	PRICE SENSITIVE	399.56KB	Share
MEM UPDATE ON LITIGATION AGAINST PRIME
11/11/16	PRICE SENSITIVE	535.03KB	Share
MEM Capital Raising and New Corporate Advisor-MEM.AX
20/09/16	PRICE SENSITIVE	271.28KB	Share
MEM Trading Halt-MEM.AX
16/09/16	PRICE SENSITIVE	518.51KB	Share
MEM Letter of Demand from PrIME and Manukan re A-Bio Debt Repaym-MEM.AX
12/09/16	PRICE SENSITIVE	255.54KB	Share
MEM Appendix 4E & FY2016 Preliminary Final Report-MEM.AX
31/08/16	PRICE SENSITIVE	218.52KB	Share
MEM Extended Date for A-Bio Debt Repayment-NSP.AX
02/06/16	PRICE SENSITIVE	313.46KB	Share
MEM PrIME Capital Raising-NSP.AX
16/05/16	PRICE SENSITIVE	403.46KB	Share
MEM Reinstatement to Official Quotation-NSP.AX
02/05/16	PRICE SENSITIVE	247.36KB	Share
MEM Continuing Negotiations on sale of B Class shares in PrIME-NSP.AX
02/05/16	PRICE SENSITIVE	485.21KB	Share
MEM Suspension from Official Quotation-NSP.AX
26/04/16	PRICE SENSITIVE	624.72KB	Share
MEM Trading Halt-NSP.AX
21/04/16	PRICE SENSITIVE	659.86KB	Share
MEM Non-Renounceable Entitlement Issue Closure
15/03/16	PRICE SENSITIVE	305.06KB	Share
MEM Replacement Prospectus
26/02/16	PRICE SENSITIVE	1.2MB	Share
MEM Appendix 4D and Half Year Report December 2015
26/02/16	PRICE SENSITIVE	1.04MB	Share
MEM University of Newcastle Agreement
22/02/16	PRICE SENSITIVE	406.04KB	Share
MEM Non-renounceable Entitlement Offer
16/02/16	PRICE SENSITIVE	389.14KB	Share
MEM Non-Renounceable Issue
16/02/16	PRICE SENSITIVE	1.79MB	Share
MEM Entitlement Offer and Appendix 3B
15/02/16	PRICE SENSITIVE	1015.08KB	Share
MEM Private placement
11/01/16	PRICE SENSITIVE	388.62KB	Share
MEM Trading Halt
07/01/16	PRICE SENSITIVE	460.21KB	Share
MEM Loan from A Goodall
18/11/15	PRICE SENSITIVE	309.48KB	Share
MEM Settlement of dispute with former Managing Director
13/11/15	PRICE SENSITIVE	116.28KB	Share
MEM Half Year Accounts
01/09/15	PRICE SENSITIVE	268.77KB	Share
MEM START OF IN-VITRO CLINICAL TRIAL AT MONASH IVF
10/08/15	PRICE SENSITIVE	503.88KB	Share
MEM Security Purchase Plan
10/08/15	PRICE SENSITIVE	1.02MB	Share
MEM Proposed Sale of Interest in PrIME Biologics Pte Limited
23/07/15	PRICE SENSITIVE	282.78KB	Share
MEM ASIC Investigation of NuSep Concluded
09/07/15	PRICE SENSITIVE	350.15KB	Share
MEM Receipt of Short Term Loan and Market Update
29/06/15	PRICE SENSITIVE	316.96KB	Share
MEM NuSep Receives Short Term Loan from Singapore Company
10/04/15	PRICE SENSITIVE	304.92KB	Share
MEM Half Yearly Report and Accounts
02/03/15	PRICE SENSITIVE	1.1MB	Share
MEM Enforceable Undertaking
18/12/14	PRICE SENSITIVE	1.46MB	Share
MEM R&D Tax Refund
18/12/14	PRICE SENSITIVE	241.56KB	Share
MEM Supply of Membranes to Prime Biologics Pte Ltd
04/11/14	PRICE SENSITIVE	305.09KB	Share
MEM NuSep signs Heads of Agreement with Minitub GmbH
04/11/14	PRICE SENSITIVE	469.25KB	Share
MEM Market Update
08/10/14	PRICE SENSITIVE	456.01KB	Share
MEM Appendix 4E
01/09/14	PRICE SENSITIVE	660.21KB	Share
MEMPayment Renegotiation for Singapore Processing Facility
05/06/14	PRICE SENSITIVE	544.51KB	Share
MEMOff Market Share Transaction
12/05/14	PRICE SENSITIVE	296.75KB	Share
MEMInvestment Transaction For PrIME Biologics Private Limited
09/05/14	PRICE SENSITIVE	324.16KB	Share
MEMTrading Halt
07/05/14	PRICE SENSITIVE	317.01KB	Share
MEMLoan Facilities
03/03/14	PRICE SENSITIVE	150.05KB	Share
MEMHalf Yearly Report and Accounts
28/02/14	PRICE SENSITIVE	366.22KB	Share
MEMPlacement
19/02/14	PRICE SENSITIVE	146.77KB	Share
MEMChange in Chief Executive Officer
11/02/14	PRICE SENSITIVE	148.01KB	Share
MEMProposed Issue of Share Options
24/01/14	PRICE SENSITIVE	56.5KB	Share
MEMNuSep Working Capital Advance
20/01/14	PRICE SENSITIVE	56.61KB	Share
MEMPrIME receives Xeraya Board conditional approval for Funding
24/12/13	PRICE SENSITIVE	56.25KB	Share
MEMPrIME signs Non Binding Funding Term Sheet
29/10/13	PRICE SENSITIVE	72.25KB	Share
MEMNuSep Receives $1.6m R&D Tax Refund
08/10/13	PRICE SENSITIVE	56.12KB	Share
MEMNuSep announces 30 June 2013 Full Year Results
30/08/13	PRICE SENSITIVE	121.92KB	Share
MEMNuSep lodges $1.6m R&D Tax Refund
23/08/13	PRICE SENSITIVE	55.01KB	Share

REFRESH

First 2

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 0.4¢		Change 0.000(0.00%)		Mkt cap ! $7.934M

Open	High	Low	Value	Volume
0.4¢	0.4¢	0.4¢	$1.8K	450K

Buyers (Bids)

No.	Vol.	Price($)
18	16151132	0.3¢

Sellers (Offers)

Price($)	Vol.	No.
0.4¢	2893900	8

View Market Depth

No.	Vol.	Price($)
18	16151132	0.003
15	21744510	0.002
8	13450024	0.001
0	0	0.000
0	0	0.000

Price($)	Vol.	No.
0.004	2893900	8
0.005	5397626	9
0.006	5039975	12
0.007	8059517	5
0.008	1682500	4

Last trade - 10.36am 11/08/2025 (20 minute delay)

MEM (ASX) Chart

MEMPHASYS LIMITED. - Announcements

Corporate Spotlight

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories